The web based app, which has been launched in association with the BSAVA, provides a library of medical summaries drawn from global guidelines and peer-reviewed journals.
Vet2Vet co-founder Dr Zoe Coker said “There is rarely time during the working day to read all the necessary journals, articles and up-to-date texts. VETbytes collates all the evidence on a specific medical condition and consolidates it into a short synopsis called a Keep it Simple Summary (KISS)."
BSAVA President Professor Ian Ramsey said: “BSAVA is excited and proud to be involved in the VETbytes project, which should provide significant benefits and support for our members. Every busy small animal clinician should try out VETbytes as it is a real paradigm shift in mobile resources for vets.”
The VETbytes app currently covers more than 100 topics developed in consultation with more than 25 veterinary experts. Further benefits include drug (and CRI) calculators, a quick reference section and links to hundreds of source abstracts. The content encourages reflective learning and can be used towards CPD hours.
VETBytes is available on subscription with reduced rates for BSAVA members and free access for veterinary students.
To start a free trial or subscribe to the VETbytes app, visit www.vetbytes.co.uk.
The company has won the Institute of Student Employers (ISE) 'Best Graduate Onboarding and Induction Activities Programme.' (Dear god. Not to take anything away from Vets4Pets' considerable achievement, but is it just me that finds it like fingernails on a blackboard when people take a perfectly serviceable preposition like 'on board' and turn it into a verb?).
Gordon Dunn, People Director at Vets4Pets, said: “As a leading UK veterinary employer, we view it as our personal responsibility to fully prepare graduates at the beginning of their career. This includes, but isn’t limited to, ensuring they are equipped with the right skills and behaviours to forge their own individual career pathway, and increase the chances of them remaining in the profession.
"The induction and onboarding of our graduates forms the lynchpin of our programme, and clearly sets out what is to come. Being recognised for the work we’re doing to develop the next generation of veterinary talent is a huge celebration for us and is a testimony to the investment made and hard work over the last few years to develop and evolve a world-class development programme. We’re extremely proud to be recognised for this achievement.”
The two companies have agreed to jointly discover and develop species-specific therapeutic monoclonal antibodies for companion animals, a class of drug which they say is neglected in veterinary medicine but offers a variety of future therapeutic options for diseases that cannot be adequately treated today.
adivo will select species-specific antibodies using its proprietary fully canine phage display library. Bayer Animal Health will provide targets involved in severe animal diseases.
Dr. Douglas Hutchens, Bayer Animal Health’s Head of Drug Discovery, External Innovation & Chief Veterinary Officer, said: "Today’s agreement is another example of how we realize our innovation strategy
"By combining the know-how from creative start-up companies like adivo with opportunities derived from Bayer’s research, we broaden our space of therapeutic medicine options and complement our portfolio.
"We are constantly looking for innovative technologies that enable us to generate novel treatment options for the companion animal sector. Now, we will focus on evolving the options presented by adivo from research and development to market maturity."
Dr. Kathrin Ladetzki-Baehs, Managing Director of adivo said: "At adivo, we truly believe that pets have a positive impact on our society. By developing novel medicines for companion animals, we want to make a difference for veterinarians and pet-parents. Today, we are more than pleased and excited to have gained such a committed and experienced collaboration partner, to jointly develop new treatment options."
The PIC decision marked the conclusion of its investigation into a concern that was raised formally last November involving allegations of bullying at Professor Argyle’s workplace, the University of Edinburgh.
Professor Argyle, who had previously decided to step aside from his JVP and Council duties until the concern was investigated and concluded, said: “Despite this outcome from the PIC discussions, I have now made the challenging decision to stand down from my position at the RCVS. This is to ensure there is no further distraction to the College’s important work and activities and that whoever becomes the next JVP has the full support of Council and RCVS members.
"It is also to reduce the toll this situation has taken on my family, colleagues and students, and on me personally. I am proud and privileged to have served on RCVS Council for nearly ten years and wish it well as it navigates the next chapter in its history."
RCVS President Mandisa Greene said: “I appreciate that this has been an exceptionally difficult situation and very upsetting for all involved.
"I understand why David has taken the difficult decision to stand down from RCVS Council and would like to thank him for his many years of service to the RCVS since joining Council in 2012.
"I would also like to reassure colleagues once again that, throughout, the College has remained firmly committed to following due, proper and fair process in all its regulatory activities."
Following Professor Argyle’s decision to step down, the process for electing a new JVP for the current presidential year will commence.
As Professor Argyle was a Veterinary Schools Council appointee on RCVS Council, it will be for that body to elect a replacement Council member.
Further details will be announced in due course.
Ficoxil contains the active ingredient firocoxib, an NSAID from the coxib class, known for its analgesic, anti-inflammatory, and antipyretic properties.
Ficoxil is available in two strengths, 57 mg and 227 mg in packs of 30.
The tablets, which are presented in presented in a divisible and blister-perforated form, are hypoallergenic, gluten-free, and come in a beef flavour of animal-free origin.
Ficoxil is available now from all major veterinary wholesalers.
https://www.fortehealthcare.com/product/ficoxil
Dechra Veterinary Products, maker of the feline hyperthyroidism treatment Felimazole®, has launched a range of waiting room materials for practices to raise awareness with owners about the disease.
Using Dechra's cartoon cat, which already features in their client booklets on feline hyperthyroidism, the materials are intended to create a focal point in the waiting room, with factual posters detailing what feline hyperthyroidism is and the symptoms to look out for. Also included is a selection of display enhancers.
The new waiting room display has been designed to complement Dechra's existing materials: client booklets, the website www.hyperthyroidcat.co.uk, website posters and hand-out cards.
Matthew Olsen, product manager at Dechra Veterinary Products said: "Our complete range of materials makes it easier for practices to communicate with owners on the subject and will help owners better understand and manage hyperthyroidism in their cats".
Practices can order their pack of waiting room materials by contacting Dechra on 01743 441632 or email marketing@dechra.com.
Sileo provides a micro-dose of dexmedetomidine hydrochloride, a selective alpha-2 adrenoceptor agonist which Zoetis says helps a dog calm down or remain calm yet fully functional in situations involving fear-eliciting sounds.
Sileo is presented as an oromucosal gel formulation in a 3ml oral syringe that can be used to apply multiple doses.
Zoetis says that its user-friendly application means that, once prescribed, it can be given by the dog owner and used only when needed for each noise anxiety event. It takes effect within 15 - 60 minutes and last for 2-3 hours. Should the fear-eliciting noise continue, further doses can be given at two hour intervals up to a total of five times during each noise event.
The company says that even when the full dosing limit is used, the dog will remain functional during treatment; the clinical effects of dexmedetomidine are dose-dependent and the anxiolytic effect is reached before the sedative effect.
Animal behaviourist, Jon Bowen BVetMed DipAS (CABC) MRCVS, said: "Fear of seasonal loud noises such as fireworks, thunder and gunshots are known to affect around 50% of the UK dog population but the prevalence of fears of other everyday noises and the extent to which those fears contribute to nuisance and problem behaviour in dogs is something we are researching at the moment. Sileo is ideal as an acute anxiolytic for planned or expected events such as fireworks or thunder, but it has an even wider range of potential applications in planned events that involve stressful noise exposure including travel, social gatherings and even visits to the vet."
Sileo is available to order now via your veterinary wholesaler.
For more information contact your Zoetis account manager or customer support on 0854 300 8034 or visit www.zoetis.co.uk/Sileo.
The final deadline for paying the fee was 31 May 2019, with the 346 who did not pay being removed on 1 June 2019, compared to 308 last year.
Those who were removed from the Register but have subsequently paid to be restored are not named on the list.
The RCVS says it sent reminders to all MsRCVS, including emails and text messages, reminding them that the fee was due. Letters were sent to those members that the College does not have an email address or mobile telephone number for.
A list of those who have not paid their fee has now been published. Practices are encouraged to check the list to ensure that no employees are named.
The College also wants to remind veterinary surgeons that, although paying the fee is required to remain on the Register, to complete their registration in full they need to confirm they are compliant with the continuing professional development (CPD) requirement and complete the criminal disclosures form. Both of these are required by the Code of Professional Conduct and can be completed on the ‘My Account’ area.
Anyone with queries about completing the registration process should contact the Registration Department on 020 7202 0707 or registration@rcvs.org.uk.
To help practices make the most of the week, TVM is providing waiting room displays, client leaflets, social media packs and online information to help educate pet owners on the symptoms of poor eye health.
The company will also be holding an webinar for vets and nurses which will be published during the week.
Will Peel, Product Manager at TVM said: "Eye problems in pets are common and brachycephalic breeds are particularly prone to them due to a number of compounding factors.
"They commonly suffer from corneal ulcers and are nearly four times more likely to develop dry eye than other breeds, so Pet Eye Health Awareness Week is focused on helping pet owners understand the issues, identify eye problems early and seek veterinary advice quickly".
www.tvm-uk.com/eyehealth
The Royal Veterinary College has announced the appointment of Professor Stuart Reid as its new Principal and the successor to Professor Quintin McKellar.
Professor Reid BVMS, PhD, DVM, DipECVPH, FRSE, MRCVS, joins the RVC from the University of Glasgow, where he was Professor of Veterinary Informatics and Epidemiology and Head of the School of Veterinary Medicine. He will take up his new role on 1st January 2011.
Professor Reid began his career in 1987 as an Assistant Veterinary Surgeon before joining the University of Glasgow as a Clinical Research Scholar in 1988. In 1992 he assumed the role of Post Doctoral Research Fellow at the University and was promoted to Senior Post-Doctoral Research Fellow in 1994. He was appointed to the first joint Chair between the Universities of Strathclyde and Glasgow in 1997, as Professor of Veterinary Informatics and Epidemiology. In 2004 he became Associate Dean of Research and, in 2005, he became Dean of the Faculty of Veterinary Medicine at the University of Glasgow.
"I am delighted and honoured to be joining the Royal Veterinary College at this important time." said Professor Reid. "The RVC has an enviable heritage and is a world leader in terms of its innovation and leadership in veterinary education, research and clinical service. I recognise that I am enormously privileged to be moving from a great School to a great College and I look forward to building on the successes achieved by RVC under Principal McKellar at the same time as rising to the challenges of a new funding environment."
Professor Quintin McKellar was appointed Principal in August 2004. He leaves the RVC to take the post of Vice-Chancellor of the University of Hertfordshire.
Chairman of the RVC Council, The Right Hon the Baroness Shephard of Northwold, said: "Great strides have been made under Professor McKellar's dynamic leadership, and I am sure I speak for all at the College when I say we will be sad to see him go. We look forward to welcoming Professor Stuart Reid, and firmly believe that his experience and distinguished academic record will assist the Royal Veterinary College in strengthening its position over the coming years."
The specialist-led lectures will start on 5th May and run until October 2021, with a session every couple of weeks, alternating between vets and nurses.
RCVS-recognised specialist in ECC, Tobias Grave, and Racheal Marshall RVN, head of clinical nursing at Vets Now, are among the speakers who will be covering topics such as damage control resuscitation, traumatic brain injury and neurotoxins. You can view the full programme here.
Dan Lewis, ECC specialist at Vets Now, who devised this year’s veterinary CPD programme, said: “Because emergencies don’t only happen out of hours we’re committed to working with general practitioners to deliver the best possible care to pets at the time they need it most. With that in mind, we are also committed to bringing relevant and pioneering CPD and training to veterinary clinicians and vet nurses.
“As emergency and critical care experts, we appreciate the value of flexibility and are always looking to adapt our services. In 2021, with social distancing still expected to be the norm, we’re offering two CPD streams, available live and on-demand.
“We delivered a successful interactive learning experience for virtual delegates through our ECC Congress at the end of last year, so we have a strong foundation from which to build on innovative and expert virtual CPD, and we’ll aim to leave delegates feeling well-informed and assured.
“We will obviously miss seeing everyone in person but gathering together online like this is beneficial as we can reach more vets and vet nurses with valuable CPD. Importantly, the format can fit around busy schedules, with all content available as videos after the events have taken place.”
Dan added: “Delegates from our ECC Congress commented on some added benefits of the virtual format including things like less environmental impact and waste through less travelling, and more flexibility due to being able to look back on the content after the event. Delegates also felt it was easier to ask questions of the speakers without feeling intimidated.”
The event series is priced at £72 for the vet stream (working out at £12 per session) and £60 for the vet nurse stream (£10 per session). You can also attend both for £110 (working out at £9.16 per session).
You can book your place at www.vets-now.com/bitesize.
Mr Beveridge had been removed from the Register following a disciplinary hearing in May 2013 in which he was found guilty of disgraceful conduct in a professional respect with the Committee finding that he had treated clients badly, kept inadequate clinical records, was dishonest in his dealings with the College and that animals in his care were placed at risk. He subsequently appealed to the Privy Council but this was later withdrawn, resulting in him being formally removed from the Register in March 2014.
He first applied to be restored to the Register in 2015 but his application was refused by the Disciplinary Committee at a hearing in November 2015. At the time the Committee found him unfit for restoration to the Register because, following his removal, his veterinary medicines account had been used on an unauthorised basis to order prescription-only veterinary medicines, which reflected a "cavalier attitude to practice". Furthermore, the Committee found that he had not fully accepted the Committee’s original findings, had made inadequate effort in regards to engaging in continuing professional development (CPD) and also considered the seriousness of the original findings.
At the opening of his second hearing Mr Beveridge, who represented himself, sought to address the concerns that the Disciplinary Committee had outlined upon refusing his first application for restoration. Regarding his acceptance of the original findings, the Committee heard that he now apologised "unreservedly for his failings that led to erasure of his name from the Register" and the Committee considered that he had demonstrated a significant change in attitude from the previous restoration hearing where he had not fully accepted the reasons for being removed.
In considering issues of public protection the Committee also accepted that Mr Beveridge, until his original Disciplinary Committee hearing, had an unblemished professional record and had run a successful small animal practice for over 30 years. It considered numerous client testimonials as well as a petition signed by 600 clients from 2013.
The Committee also considered that there was no risk to the future welfare of animals in the event of Mr Beveridge being restored to the Register, noting the testimonials and references to satisfactory care and treatment given by Mr Beveridge to his patients.
Regarding CPD, Mr Beveridge produced evidence before the Committee that he had attended courses run by the North American Veterinary Community (NAVC) and the British Small Animal Veterinary Association (BSAVA). The Committee accepted that he had made "considerable progress" in terms of CPD.
In concluding the hearing Judith Way, chairing the Committee and speaking on its behalf, said: "It is the judgement of the Committee that the conduct which resulted in the applicant’s name being removed from the Register is unlikely to be repeated. The applicant has satisfied the Committee that he is fit to be restored to the Register."
The new 'SMART goals tool' is an addition to the charity's Farm Vet Champions programme, which supports veterinary teams with knowledge and resources to ensure antimicrobials are used responsibly.
To support the take-up of the new SMART goals tool, RCVS Knowledge will be running a free webinar on Zoom at 12:30pm on Tuesday 17th May (register here).
Fiona Lovatt, Farm Vet Champions Clinical Lead, said: “It is such a critical time to ensure we are using antimicrobials responsibly so that they will work when patients really need them.
"We all have a responsibility to fight antimicrobial resistance. The good news is there is a lot we can do – one of those things is getting involved with Farm Vet Champions, enhancing our skills and adapting our practice.
“I am so excited to see the launch of our SMART goal tool. It is both engaging and simple to use, and I expect it will encourage practice teams to motivate each other to track their progress in their stewardship activities.
Fraser Broadfoot, Head of Antibiotic Use and Stewardship Team at Veterinary Medicines Directorate, said: “We are really supportive of this important initiative.
"In the UK we have seen a 52% reduction in antibiotic use for food producing animals since 2014, and this has been driven by vets and farmers working together to reduce unnecessary use of antibiotics and with a strong focus on disease prevention.
"However, as highlighted in the RUMA sector targets, there are still areas where improvements can be made and where antibiotic use data is lacking.
"This SMART goals tool therefore provides an easy-to-use and practical resource that is designed to help and motivate vets and practice teams to set, monitor and accomplish goals and build on the tremendous progress that they have already achieved.
"This will not only help the livestock sectors to achieve their targets, but will result in improvements in animal health and, by reducing the burden of resistant bacteria, have public health benefits too.”
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
At the outset of the hearing, Mr Kashiv, from Vets & Pets, Broxbourne, denied all aspects of the charges against him. During the course of the inquiry, some heads of charge were not pursued and some he admitted, leaving the remaining heads of charge to be determined.
The charges concerned the treatment of a Scottish Terrier, called Tanzy, whose owner, Mrs Greenhill, brought her in to see Mr Kashiv on 5 March 2015. Mrs Greenhill was concerned about blood in Tanzy’s urine and swellings in her mammary glands. After carrying out a cytopathology test, Mr Kashiv advised Mrs Greenhill that Tanzy would require surgery to remove the mammary glands. There were no further tests conducted, and no alternatives to surgery suggested.
On 13 March another veterinary surgeon at Vets & Pets therefore undertook a right-side mammary strip on Tanzy, discharging her the following day. On 17 March Mrs Greenhill brought Tanzy back in for a post-operative check and was seen by a locum veterinary surgeon, who found her to be in good condition.
On 20 March Mrs Greenhill then became concerned about Tanzy’s deteriorating condition and returned her to see Mr Kashiv. He admitted Tanzy for observation over the weekend but did not conduct any further tests at that stage, apart from radiography on 22 March. The hospitalisation records were of poor quality and substantially incomplete.
On 23 March Mr Kashiv then informed Mrs Greenhill that Tanzy could be discharged, although he recommended an MRI scan to assist in the diagnosis; this was declined on cost grounds. He did not however explain clearly to Mrs Greenhill that Tanzy’s prognosis was bleak, and did not give adequate home care instructions.
Tanzy continued to deteriorate, and on 24 March Mrs Greenhill took Tanzy to the RSPCA Harmsworth Hospital where a veterinary surgeon conducted tests which showed that Tanzy was in renal failure. The veterinary surgeon then called Mrs Greenhill and recommended that Tanzy was put to sleep, which was then performed in Mrs Greenhill’s presence.
The Committee found that Mr Kashiv had failed to conduct the necessary investigations when Tanzy was admitted from 20 to 23 March 2015, being satisfied that, by the time Tanzy had been hospitalised for a period of three days, it was mandatory for a blood test to have been performed, given her marked deterioration.
The Committee also found while Mr Kashiv did express his opinion that Tanzy’s prognosis was poor, he did not give the full explanation required in the circumstances of this case to enable Mrs Greenhill to understand fully the prognosis. The Committee also considered that Tanzy was not in a fit state to be discharged on 23 March 2015, and that he had failed to keep sufficiently clear and/or detailed and/or accurate records.
After full consideration, the Committee found that Mr Kashiv’s actions amounted to serious professional misconduct, and was satisfied that his actions fell far short of the conduct to be expected of a reasonably competent veterinary surgeon in respect of heads of charge 1, 2 and 3 but not 4.
Although it was concerned "about the culture of care in the practice, in particular not having in place proper protocols and procedures and without necessary support from properly trained staff", in deciding on appropriate sanction, the Committee was satisfied that there were "a number of serious misjudgements by Mr Kashiv in this case".
The Committee decided to postpone judgement for a period of two years, whilst recommending that Mr Kashiv agree to undertake a structured programme to benefit his clinical practice including a Personal Development Plan, mentoring, practice visits, additional CPD and regular reports to the Disciplinary Committee.
Non-compliance with these undertakings may result in the hearing being resumed at a date earlier than the two-year period.
Stuart Drummond, Chairing the Disciplinary Committee and speaking on its behalf, said: "The Committee considers that Mr Kashiv is a dedicated veterinary surgeon, as evidenced by the large number of testimonials, and that he provides a valuable service to the community, particularly with rescue animals.
"Nevertheless, the Committee considers that there were a number of fundamental failings in Mr Kashiv’s clinical competence which are required to be addressed during the period of postponement. For the reasons set out above the Committee considers that Mr Kashiv’s clinical practice will benefit from a structured programme over the period of postponement, whilst protecting the welfare of animals, maintaining public confidence in the profession and declaring and upholding proper standards of conduct."
For the full charges, findings and decisions, see: http://www.rcvs.org.uk/concerns/disciplinary-hearings/
The booklet contains practical advice on handling rabbits, anaesthetic drugs, procedures and what to look out for from the moment the rabbit arrives into the practice up to recovery and homecare. Special attention is given to reducing anxiety in rabbit patients as much as possible at every stage.
Topics covered in the booklet include: medications in rabbits generally used according to the UK prescribing cascade, preparing for rabbit anaesthesia in clinic, staff training, an overview of anaesthetic drugs, the induction process and important points of difference, monitoring and recovery and adjunctive treatments.
Richard Beckwith, country manager of Jurox said: "Rabbits are prey species and often become stressed in the veterinary practice environment which can have a negative impact during anaesthesia and post-anaesthesia. Our new Considerations for Anaesthetising Rabbits expert panel guidelines booklet will help address this and raise anaesthesia and analgesia standards in veterinary practices."
For more information, visit www.alfaxan.co.uk, contact Jurox customer services on info@jurox.co.uk or telephone 0800 500 3871.
Elisa, pictured right next to Bill Oddie, is the founding member of a craft conservation charity called Blankets for Baby Rhinos. In less than three years the group has amassed a Facebook community of around 3,500 members, primarily knitters, crocheters and crafters, to make blankets and other items to supply to wildlife centres taking in orphaned and sick rhinos in Africa, as well as other wildlife threatened by poaching.
Originally from South Africa, Johannesburg-born Elisa had planned to work as a vet treating wildlife but found herself working in small animal practice in Cape Town before moving to the UK.
Still, colleagues and friends often told her of the injuries they saw inflicted on rhinos targeted for the illegal trade in their horns, so she and a friend decided to help.
After building a following and supplying thousands of blankets for a growing number of wildlife orphanages in Africa, she wanted to harness the enthusiasm of members to help meet the other practical needs of the centres, as well as helping rangers and dogs working in anti-poaching units.
Now a registered charity, members supply all kinds of equipment including animal feed, medicine and veterinary supplies to a wide list of centres, as well as food for anti-poaching dogs while continuing to run appeals which crafters can assist with. Currently they are asking knitters to knit hats, scarves and blankets in black or dark colours for rangers, so they can keep warm at night without being spotted by poachers.
James Sawyer, UK Director of IFAW, said: "Elisa’s pioneering approach to harnessing practical public support to help rhinos and other rescued African wildlife is really impressive and she is a great example of animal welfare in action. We hope her efforts will inspire the next generation of animal welfare and conservation campaigners. She is a very deserving winner of IFAW’s Vet of the Year Award."
The company has also carried out research amongst 60 practices which found that despite the fact that over 80% of dogs over the age of three reportedly suffer from dental disease1, only 48% opened discussions about dental care at the earliest opportunity: vaccination time. 16% only discussed dental care if the dog developed a dental problem and 52% also admitted that they did not follow up discussions on dental compliance.²
Eleanor Workman Wright, Product Manager at Animalcare, said: "The key to successful dental care is to start early, both in educating owners and getting puppies and kittens used to brushing or other forms of dental care. If discussions are delayed until the animal is a year old, it is possible that some disease may already be present while the animal may be less receptive to brushing or other efforts to care for their teeth.
"We see the dental sector as important and one that is likely to grow, particularly in the light of the pandemic-induced increase in the number of dogs and cats. We hope that our new Owner Guide will support veterinary teams in initiating early discussions with owners about the importance of dental care, while the addition of an affordable and effective oral gel in Orozyme, to our range will give them a key tool to offer to owners to use as part of their homecare routine."
For more information, contact your Animalcare Territory Manager or visit: www.animalcare.co.uk .
Reference
In common with the various other telemedicine platforms which have come to market in recent months, the app will allow veterinary professionals to give help and advice to clients and maintain a revenue stream whilst maintaining social distancing.
VisioCare is highlighting a number of features over and above standard video conferencing, including the ability for the clinician to take photos, video and produce a case file that can be added to the clinical record. The system also allows vets to access the client's smartphone and zoom into areas that need to be examined or turn on a flashlight to improve visibility.
Visiocare says it has also been able to address limitations in clarity due to poor smartphone reception.
Linkyvet includes a payment module - which will be integrated free of charge for orders taken during April - so practices can charge for services provided remotely.
Alexander Arpino, Managing Director of Veterinary Insights, said: "During the current COVID-19 situation, Linkyvet has real potential for triage, as well as enabling routine consultations, without putting anyone at risk. It's good news for patient care, staff wellbeing and also ensuring that the practice remains a viable business that's still there for everyone to return to when life returns to normality.
"Outside crisis times, the tool has ongoing value, providing a great way to generate revenue from services such as advisory consultations and follow ups provided remotely and giving clients a convenient alternative to visiting the practice."
VisioCare Linkyvet is available as a standalone tool or can be included in a bundle with other VisioCare products such as VisioCare Consult, which provides explanatory animations and videos that support clinician recommendations and the myBuddy app, which provides a secure and personalised communication channel between clinic and pet owner.
For more information, visit www.visiocareservices.com or contact your VisioCare Business Development Manager: telephone 01403 800135 or email enquiries@visiocareservices.com.
21-year-old Amber recently graduated with a first class degree in Zoology from the Anglia Ruskin University in Cambridge and was then offered one of 72 places at Harper and Keele Veterinary School.
However, because it is her second degree, she is not eligible for a student fee loan. Whilst she has been able to save enough for her first year at vet school, she doesn't have the £37,000 needed to fund the other four. The pandemic is also making it harder to earn more money to put towards her career, as she has had to shield with her grandmother.
To try and make up the shortfall, Amber set up a gofundme page (https://www.gofundme.com/f/amberintovetmed) and contacted KentOnline and VetSurgeon.org to try and get some publicity for her fundraising efforts, and to highlight the financial barrier for working class people like her who are trying to fulfill their dream to become a veterinary surgeon. She has already raised £933.
Amber has made a video about her story, which you can watch on her fundraising page, or on YouTube here: https://www.youtube.com/watch?v=WTTpAiNvz8g
Meanwhile, she has deferred her entry to vet school until she can secure further funding.
Talking about her longer term ambition, Amber said: "Being within the BAME community myself, black in STEM, and coming from a working class background, I want to be an advocate and an affiliate for students who shall face the same challenges and wish to pursue this upon becoming a vet. I also want to contribute to wildlife and conservation and the one health initiative."
For more information, or to contact Amber, visit: https://www.linkedin.com/in/amber-cordice-0121a41b0
The Open Access Publication Charge (OAPC) initiative was introduced in 2021 to cover the fees for the company's employees to publish in prominent peer-reviewed veterinary journals, which can cost up to £3,000 per paper.
Funding was approved for 29 employees to have their work published in eight journals last year, covering topics such as canine mast cell tumours, imaging of canine intracranial intra-axial haemorrhages, electrochemotherapy as a treatment option for feline nasal melanoma and antimicrobial use in female canine urinary tract infections.
The OAPC scheme has now been extended with a fund of at least £30,000 available this year.
The initiative was introduced by Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus and a specialist in veterinary neurology (pictured right).
She said: “By publishing in open access journals, we are ensuring that research at Linnaeus is freely available across the veterinary profession and the scientific community.
“Being able to publish high-quality research in prestigious scientific journals supports the career development and job satisfaction of our Associates and fulfils the requirements of those training to become specialists.”
Dr Fabio Stabile, a neurology specialist at Southfields Veterinary Specialists, has been researching how dogs with reactive seizures can be treated with levetiracetam.
He said: “By publishing through open-access journals, I hope to support as many peers as possible with treating canine reactive seizures, which can be extremely stressful for our patients and their owners. It is always great collaborating with Luisa in developing my research, which was as valuable as the OAPC funding itself.”
In addition to the funding scheme, Linnaeus has also appointed Hannah Sargent as Clinical Research Associate to help researchers in areas such as study design, ethical review and statistical analysis.
For more information, visit https://www.linnaeusgroup.co.uk/medical-and-nursing/clinical-research.
MSD Animal Health (Merck in the US and Canada), has launched Finadyne (flunixin), the NSAID for cattle, as a pour on.
According to the company, Finadyne Transdermal is the world's first non-parasiticide cattle product to be made available as a pour-on.
Dr. Martin Behr, technical manager at MSD Animal Health said: “Finadyne Transdermal is uniquely designed for rapid absorption into the bloodstream and its antipyretic effect has been demonstrated as early as two hours after treatment. This is because innovative penetration enhancers are included in the formulation to improve the absorption of the active ingredient flunixin through the skin.”
The new product comes in pre-calibrated packaging and uses a bottle designed for easy application along an animal’s back.
Dr. Behr added: “It’s much simpler for farmers to treat cattle in this way – as opposed to administering an injection, which can also mean needle-site lesions that can reduce the value of a carcass or compromise hide quality.
“The time taken to handle and treat animals will be much reduced with a transdermal NSAID. There will also be a saving on syringes and needles.”
Finadyne Transdermal (POM-V) is available now from veterinary wholesalers. Further information is available from the MSD Animal Health veterinary support group on 01908 685685.
The project, which is funded by the RCVS Mind Matters Initiative, is designed to find out about current attitudes, beliefs, and alcohol use behaviours of those working in clinical settings within the UK veterinary sector.
Researchers Dr Jennifer Seddon, Olivia Cormier MRCVS, and Dr Emma Davies, from Oxford Brookes University are inviting people aged 18 and over who are working in the UK veterinary sector, including vets, veterinary nurses, practice managers, veterinary care assistants, receptionists, and those undertaking other in-practice roles, who currently drink or have drunk alcohol in the past three months to take part in an online survey which takes no more than 15 minutes.
Olivia said: “Evidence from research conducted in 2009 showed that veterinary professionals may be more likely to drink at risky levels compared to people in the general population.
"There is a vital need for new research in this area, not only so we can better understand what the current situation looks like, but so that we can learn how best to provide tailored support to this group.”
The survey is anonymous and confidential, and no personal data will be gathered or shared with MMI or the RCVS.
After completing the survey, participants can choose to enter a prize draw to win one of three £100 Amazon vouchers.
https://brookeshls.co1.qualtrics.com/jfe/form/SV_0pHn8qy4ZIVTTgy
Photo: www.depositphotos.com
The College has confirmed that it has now received an official complaint about the matter and it is now investigating under its normal 'concerns' investigation process.
Professor Argyle made a private statement about the allegations to RCVS Council at its meeting today, having already answered written questions from a number of Council members in the preceding days.
The Council did not ask Professor Argyle to step aside, but acknowledged that this was his choice, made for personal reasons.
The College said that in line with its normal protocols, and to ensure fairness for all parties, it will not make any further public comment about the investigation for the time being. However, it wanted to stress that it remains firmly committed to following due and proper process in all its regulatory activities.
The gallery was traditionally held in-person at the NAVC’s annual Veterinary Expo & Meeting (VMX) in Florida.
Now, for the first time since it began in 2012, the gallery is accessible to everyone everywhere months before the live event in June.
The new Virtual VMX New Product Gallery went live this week and will run until 3rd September 2021. It showcases 21 new product innovations from the following companies: BioNote; Boehringer Ingelheim Animal Health; Dechra Veterinary Products; Epicur Pharma; GVL; Hill’s Pet Nutrition, Inc.; Merck Animal Health; Neogen Corporation; Ogena Solutions; Purina; Royal Canin; Vetoquinol; Zoetis Petcare.
NAVC CEO Gene O’Neill said: "Each year, NAVC’s panel of experts select the most innovative new products and services to be showcased as part of the VMX Expo. We are excited to take this VMX staple and, for the first time, make it universally available to members of our global veterinary community everywhere.
"And they don’t have to wait until June to learn about and try these important new products. The VMX Virtual New Product Gallery launch is part of the NAVC’s expanding virtual portfolio which breaks down barriers of geography and time to make the best products the veterinary industry has to offer available to veterinary professionals worldwide.” The gallery is free to access. You can register here: https://vmxvirtual.simexpo.com/page/100